Skip to main content
Top
Published in: Diabetologia 12/2012

01-12-2012 | Article

Implementation of the automated Leicester Practice Risk Score in two diabetes prevention trials provides a high yield of people with abnormal glucose tolerance

Authors: L. J. Gray, K. Khunti, C. Edwardson, S. Goldby, J. Henson, D. H. Morris, D. Sheppard, D. Webb, S. Williams, T. Yates, M. J. Davies

Published in: Diabetologia | Issue 12/2012

Login to get access

Abstract

Aims/hypothesis

The Leicester Practice Risk Score (LPRS) is a tool for identifying those at high risk of either impaired glucose regulation (IGR), defined as impaired glucose tolerance and/or impaired fasting glucose, or type 2 diabetes from routine primary care data. The aim of this study was to determine the yield from the LPRS when applied in two diabetes prevention trials.

Methods

Let’s Prevent Diabetes (LPD) and Walking Away from Diabetes (WAD) studies used the LPRS to identify people at risk of IGR or type 2 diabetes from 54 general practices. The top 10% at risk within each practice were invited for screening using a 75 g OGTT. The response rate to the invitation and the prevalence of IGR and/or type 2 diabetes in each study were calculated.

Results

Of those invited 19.2% (n = 3,449) in LPD and 22.1% (n = 833) in WAD attended. Of those screened for LPD 25.5% (95% CI 24.1, 27.0) had IGR and 4.5% (95% CI 3.8, 5.2) had type 2 diabetes, giving a prevalence of any abnormal glucose tolerance of 30.1% (95% CI 28.5, 31.6). Comparable rates were seen for the WAD study: IGR 26.5% (95% CI 23.5, 29.5), type 2 diabetes 3.0% (95% CI 1.8, 4.2) and IGR/type 2 diabetes 29.5% (95% CI 26.4, 32.6).

Conclusions/interpretation

Using the LPRS identifies a high yield of people with abnormal glucose tolerance, significantly higher than those seen in a population screening programme in the same locality. The LPRS is an inexpensive and simple way of targeting screening programmes at those with the highest risk.
Literature
1.
go back to reference Gillies CL, Abrams KR, Lambert PC et al (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334:299PubMedCrossRef Gillies CL, Abrams KR, Lambert PC et al (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334:299PubMedCrossRef
2.
go back to reference Gillies CL, Lambert PC, Abrams KR et al (2008) Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 336:1180–1185PubMedCrossRef Gillies CL, Lambert PC, Abrams KR et al (2008) Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 336:1180–1185PubMedCrossRef
3.
go back to reference Collins GS, Mallett S, Omar O, Yu L (2011) Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med 9:103PubMedCrossRef Collins GS, Mallett S, Omar O, Yu L (2011) Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med 9:103PubMedCrossRef
4.
go back to reference Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164–171PubMedCrossRef Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164–171PubMedCrossRef
5.
go back to reference Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 388:b880CrossRef Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 388:b880CrossRef
6.
go back to reference Gray LJ, Davies MJ, Hiles S et al (2012) Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia 55:959–966PubMedCrossRef Gray LJ, Davies MJ, Hiles S et al (2012) Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia 55:959–966PubMedCrossRef
7.
go back to reference Gray LJ, Taub N, Khunti K et al (2010) The Leicester Risk Assessment score for detecting undiagnosed type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med 27:887–895PubMedCrossRef Gray LJ, Taub N, Khunti K et al (2010) The Leicester Risk Assessment score for detecting undiagnosed type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med 27:887–895PubMedCrossRef
8.
go back to reference Chatterton H, Younger T, Fischer A, Khunti K, on behalf of the Programme Development Group (2012) Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance. BMJ 345:e4624PubMedCrossRef Chatterton H, Younger T, Fischer A, Khunti K, on behalf of the Programme Development Group (2012) Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance. BMJ 345:e4624PubMedCrossRef
9.
go back to reference World Health Organization (1999) Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Report. World Health Organization, Geneva World Health Organization (1999) Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Report. World Health Organization, Geneva
10.
go back to reference Gray LJ, Khunti K, Williams S et al (2012) Let’s Prevent Diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation. Cardiovasc Diabetol 11:56PubMedCrossRef Gray LJ, Khunti K, Williams S et al (2012) Let’s Prevent Diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation. Cardiovasc Diabetol 11:56PubMedCrossRef
11.
go back to reference Yates T, Davies MJ, Henson J et al (2012) Walking away from type 2 diabetes: trial protocol of a cluster randomized controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes. BMC Fam Pract 13:46PubMedCrossRef Yates T, Davies MJ, Henson J et al (2012) Walking away from type 2 diabetes: trial protocol of a cluster randomized controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes. BMC Fam Pract 13:46PubMedCrossRef
12.
go back to reference American Diabetes Association (2010) Standards of medical care in diabetes—2010. Diabet Care 33:S11–S61CrossRef American Diabetes Association (2010) Standards of medical care in diabetes—2010. Diabet Care 33:S11–S61CrossRef
13.
go back to reference Webb D, Khunti K, Srinivasan B et al (2010) Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening. Trials 19:16CrossRef Webb D, Khunti K, Srinivasan B et al (2010) Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening. Trials 19:16CrossRef
14.
go back to reference Webb DR, Gray LJ, Khunti K et al (2011) Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia 54:2237–2246PubMedCrossRef Webb DR, Gray LJ, Khunti K et al (2011) Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia 54:2237–2246PubMedCrossRef
15.
go back to reference van den Donk M, Sandbaek A, Borch-Johnsen K et al (2011) Screening for type 2 diabetes. Lessons from the ADDITION-Europe study. Diabet Med 28:1416–1424PubMedCrossRef van den Donk M, Sandbaek A, Borch-Johnsen K et al (2011) Screening for type 2 diabetes. Lessons from the ADDITION-Europe study. Diabet Med 28:1416–1424PubMedCrossRef
16.
go back to reference Khunti K, Taub N, Gillies C et al (2012) A comparison of cost per case detected of screening strategies for type 2 diabetes and impaired glucose regulation: modelling study. Diabetes Res Clin Pract. doi:10.1016/j.diabres.2012.03.009 Khunti K, Taub N, Gillies C et al (2012) A comparison of cost per case detected of screening strategies for type 2 diabetes and impaired glucose regulation: modelling study. Diabetes Res Clin Pract. doi:10.​1016/​j.​diabres.​2012.​03.​009
17.
go back to reference Dalton ARH, Bottle A, Okoro C, Majeed A, Millett C (2011) Uptake of the NHS Health Checks programme in a deprived, culturally diverse setting: cross-sectional study. J Public Health 33:422–429CrossRef Dalton ARH, Bottle A, Okoro C, Majeed A, Millett C (2011) Uptake of the NHS Health Checks programme in a deprived, culturally diverse setting: cross-sectional study. J Public Health 33:422–429CrossRef
18.
go back to reference Waugh N, Scotland G, McNamee P et al (2007) Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess 11:1–125 Waugh N, Scotland G, McNamee P et al (2007) Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess 11:1–125
19.
go back to reference Eborall H, Stone M, Aujla N, Taub N, Davies M, Khunti K (2012) Influences on the uptake of diabetes screening: a qualitative study in primary care. Br J Gen Pract 62:e204–e211PubMedCrossRef Eborall H, Stone M, Aujla N, Taub N, Davies M, Khunti K (2012) Influences on the uptake of diabetes screening: a qualitative study in primary care. Br J Gen Pract 62:e204–e211PubMedCrossRef
20.
go back to reference Griffin SJ, Borch-Johnsen K, Davies MJ et al (2011) Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 378:156–167PubMedCrossRef Griffin SJ, Borch-Johnsen K, Davies MJ et al (2011) Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 378:156–167PubMedCrossRef
21.
go back to reference Gray LJ, Tringham J, Davies MJ et al (2010) Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study. Vasc Health Risk Manag 6:837–842PubMedCrossRef Gray LJ, Tringham J, Davies MJ et al (2010) Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study. Vasc Health Risk Manag 6:837–842PubMedCrossRef
22.
go back to reference World Health Organization (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. World Health Organization, Geneva World Health Organization (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. World Health Organization, Geneva
23.
go back to reference de Lusignan S, van Weel C (2006) The use of routinely collected computer data for research in primary care: opportunities and challenges. Fam Pract 23:253–263PubMedCrossRef de Lusignan S, van Weel C (2006) The use of routinely collected computer data for research in primary care: opportunities and challenges. Fam Pract 23:253–263PubMedCrossRef
Metadata
Title
Implementation of the automated Leicester Practice Risk Score in two diabetes prevention trials provides a high yield of people with abnormal glucose tolerance
Authors
L. J. Gray
K. Khunti
C. Edwardson
S. Goldby
J. Henson
D. H. Morris
D. Sheppard
D. Webb
S. Williams
T. Yates
M. J. Davies
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2725-8

Other articles of this Issue 12/2012

Diabetologia 12/2012 Go to the issue